SCHEMBL31056884

SCHEMBL31056884

COC(=O)c1ccc(B2OC(C)(C)C(C)(C)O2)c2ccn(C(=O)OC(C)(C)C)c12

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
BUB1 O43683 1/20 0.35
USP30 Q70CQ3 2/20 0.34
PRMT5 O14744 1/20 0.34
WDR77 Q9BQA1 1/20 0.34
AAK1 Q2M2I8 1/20 0.32
DGAT1 O75907 1/20 0.31
PKM P14618 1/20 0.31
NR1H2 P55055 1/20 0.31
UCHL1 P09936 1/20 0.31
EED O75530 1/20 0.31
RBBP4 Q09028 1/20 0.31
SUZ12 Q15022 1/20 0.31
EZH2 Q15910 1/20 0.31
AEBP2 Q6ZN18 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29326532 1.00 BUB1 (0.35) BUB1USP30PRMT5WDR77AAK1
SCHEMBL16336927 0.85 BUB1 (0.37) BUB1USP30PRMT5WDR77AAK1
SCHEMBL18487465 0.84 BUB1 (0.38) BUB1USP30PRMT5WDR77AAK1
SCHEMBL24077259 0.84 KMT2A (0.36) USP30PRMT5WDR77AAK1MEN1
SCHEMBL21652828 0.77 BUB1 (0.38) BUB1USP30PRMT5WDR77AAK1
SCHEMBL30951333 0.77 BUB1 (0.36) BUB1USP30PRMT5WDR77AAK1
SCHEMBL29326541 0.77 BUB1 (0.36) BUB1USP30PKMNR1H2UCHL1
SCHEMBL31056574 0.77 BUB1 (0.36) BUB1USP30PKMNR1H2UCHL1
SCHEMBL715654 0.77 BRD4 (0.39) BUB1USP30PRMT5WDR77AAK1
SCHEMBL30606423 0.77 BRD4 (0.39) BUB1USP30PRMT5WDR77AAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed